‘Miracle’ Cystic Fibrosis Drug Kept Out of Reach in Developing Countriesnews2023-02-07T21:15:45+00:00February 7th, 2023|The New York Times|
Fabricantes de vacunas se quedaron con 1400 millones USD en anticiposnews2023-02-04T10:00:24+00:00February 4th, 2023|The New York Times|
Covid Vaccine Makers Kept Prepayments for Canceled Shots for Poor Nationsnews2023-02-01T17:44:17+00:00February 1st, 2023|The New York Times|
Countries Need to Make Their Own Vaccines. Why Isn’t the U.S. Embracing This Pandemic Prevention Strategy?news2022-12-06T20:59:36+00:00December 6th, 2022|The New York Times|
Indian Drugs, Sold Worldwide, Sometimes Deadlynews2022-11-03T15:02:03+00:00November 3rd, 2022|The New York Times|
¿Las nuevas vacunas contra la malaria podrán erradicarla?news2022-10-08T09:00:27+00:00October 8th, 2022|The New York Times|
Can New Vaccines Finally Eradicate Malaria?news2022-10-04T10:12:35+00:00October 4th, 2022|The New York Times|
Un nuevo tratamiento contra el VIH ha probado ser un éxito. ¿Será accesible en África?news2022-09-30T09:00:20+00:00September 30th, 2022|The New York Times|
A New Shot Guards Against H.I.V., but Access for Africans Is Uncertainnews2022-09-27T07:00:12+00:00September 27th, 2022|The New York Times|
Monkeypox Shots, Treatments and Tests Are Unavailable in Much of the Worldnews2022-09-12T11:30:34+00:00September 12th, 2022|The New York Times|
